| Health / Medical Topics |
Yttrium Y 90-DOTA-tyr3-octreotide
Pronunciation
A substance being studied in the treatment of some types of cancer. Yttrium Y 90-DOTA-tyr3-octreotide contains a molecule that binds to a protein found on certain types of neuroendocrine tumors (tumors that form from cells that release hormones). It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-DOTA-tyr3-octreotide is a type of radioconjugate. Also called yttrium Y 90-edotreotide and yttrium Y 90-SMT 487. (NCI Dictionary)
YOU MAY ALSO LIKE
A radioconjugate of biotin and yttrium Y 90 (Y-90) linked through the bifunctional macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA) with radioimmunotherapy…
A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 contains a monoclonal antibody that…
A substance being studied in the treatment of liver cancer. HuAFP31 is a monoclonal antibody that can bind to tumor cells that…
A substance being studied in the treatment of some types of cancer. M5A is a monoclonal antibody that binds to a protein…
A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90-clivatuzumab tetraxetan contains a monoclonal antibody that binds to…
A substance being studied in the treatment of some types of cancer. Yttrium Y 90 SMT 487 contains a molecule that binds…
